Abstracts and reference lists, where the speaker has made these available, are available by clicking on the lecture titles below.

• The molecular pathology of breast cancer Professor Carlos Caldas University of Cambridge, UK
• Future classification of breast cancer Professor Ian Ellis University of Nottingham, UK.
• Traditional histological prognostic factors in breast carcinoma Professor Christopher Elston Nottingham City Hospital, UK
• Do stem cells exist in the breast and how to utilise luminal and basal markers in diagnosis of intraductal epithelial proliferations? Professor Werner Boecker - University of Munster Germany
• Familial and basal-type breast carcinoma Dr Jorge Reis-Filho The Breakthrough Toby Robins Breast Cancer Research Centre
• Columnar cell lesions Professor Stu Schnitt Beth Israel Deaconess Medical Center, Harvard Medical School Boston, USA
• In situ and invasive lobular neoplasia Professor Andy Hanby Leeds, UK
• An update on the pathology of DCIS Dr Sarah Pinder Cambridge University, UK
• An update on predictive factors in breast cancer, including HER2 - from bench to bedside. Dr John Bartlett Glasgow
• An update on trastuzumab (Herceptin) and new chemotherapy regimens. Dr Paul Ellis Guy's Hospital, London.

Slide Seminar

Answers are now available here

Two cases each from:

• Dr Daniel Faverly (Brussels, Belgium)
• Dr Hans Peterse (Amsterdam, Netherlands)
• Dr Cecily Quinn (Dublin, Ireland) Anwser 1, answer 2
• Dr Andrew Lee (Nottingham, UK)
• Professor Stu Schnitt (Boston, USA)

The meeting was developed by Dr Sarah Pinder, to whom constructive comments may be addressed at: sep43@cam.ac.uk

Constructive suggestions and requests for more information about this or any other BDIAP meeting may be addressed to the Meetings Secretary, Dr Bryan Warren

or the BDIAP Administrative Secretary, Mrs C. Harris